Lifeworks Advisors’s Boston Scientific BSX Stock Holding History

Lifeworks Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$523K	Sell	8,342 -140	-2%	-$11.2K	0.07%	190
2025 Q4	$809K	Buy	8,482 +630	+8%	+$61.8K	0.1%	158
2025 Q3	$767K	Buy	7,852 +895	+13%	+$92.7K	0.1%	161
2025 Q2	$747K	Sell	6,957 -579	-8%	-$58.6K	0.11%	156
2025 Q1	$760K	Buy	7,536 +1,509	+25%	+$152K	0.13%	148
2024 Q4	$538K	Buy	6,027 +1,374	+30%	+$121K	0.1%	160
2024 Q3	$390K	Buy	4,653 +1,515	+48%	+$119K	0.08%	194
2024 Q2	$242K	Buy	+3,138	New	+$230K	0.07%	200

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lifeworks Advisors's BSX Position: Q1 2026 in Review

Lifeworks Advisors reduced its Boston Scientific (BSX) stake by 1.7% in Q1 2026, selling an estimated $11.2K and leaving 8,342 shares worth $523K. The position accounts for 0.07% of the portfolio, ranked #190.

Lifeworks Advisors first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $809K in Q4 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Lifeworks Advisors held 8,342 shares of Boston Scientific worth $523K as of Q1 2026.
Lifeworks Advisors sold 140 Boston Scientific shares in Q1 2026, an estimated $11.2K.
Boston Scientific made up 0.07% of Lifeworks Advisors's portfolio in Q1 2026, its #190 holding.
Lifeworks Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
Lifeworks Advisors's Boston Scientific position peaked at $809K in Q4 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.